![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Biol Chem, Vol. 275, Issue 20, 15014-15018, May 19, 2000
1 Core Activation Domain*
§¶,
, and
§
From the
Department of Biosciences, Karolinska
Institutet, Novum, Huddinge S-141 57, Sweden and
§ Södertörns Högskola, Box 4101, Huddinge S-141 04, Sweden
| |
ABSTRACT |
|---|
|
|
|---|
A 58-amino acid region mediates the core
transactivation activity of the glucocorticoid receptor Transcriptional regulatory proteins are often composed of domains
that can function independently of the other parts of the protein. It
is generally accepted that these proteins can be subdivided into fully
functional DNA-binding domains and activation domains. In the case of
activation domains, the concept of modularity has been extended to
suggest that these domains are themselves built up of short peptide
modules that contribute to gene activation independently of each other
but in a synergistic manner (1-5). These ideas lead to the suggestion
that even though the subdomains could employ distinct mechanisms, they
may be functionally redundant and that it would be the number rather
than the composition of the submodules in an activation domain that is
of importance for its gene activation potential.
The glucocorticoid receptor
(GR)1 belongs to the large
family of ligand-inducible nuclear receptors that function by
modulating the transcription of target genes (6, 7). The
transactivation activity of the human GR is mainly mediated by two
domains, Similar to the transactivation domains of VP16 (21, 22) and NF- If this model is correct for the Strains and Plasmids
Strains--
The Saccharomyces cerevisiae
strain W303-1A (MATa, ade2-1°,
can1-100°, his3-11, 15, leu2-3,
112, trp1-1a, ura3-1) was used as
the yeast host cell for all experiments in the study. The
Escherichia coli strain BL21(DE3)plysS (Novagen) was used
for GST and GST fusion protein expression.
Plasmids--
pKVBB-GRDBD- Transactivation Assay in Yeast
Plasmids were transformed into the yeast strains using a
spheroplast procedure (31). Several colonies from each transformation were checked on 5-bromo-4-chloro-3-indolyl- Western Blot Detection of Proteins in Whole Cell Yeast
Extracts
Yeast extracts were prepared using the rapid protein extraction
procedure described by Horvath and Riezman (34). The proteins in the
extracts were separated by SDS-polyacrylamide gel electrophoresis using
12% polyacrylamide resolving gels and then electrophoretically transferred to Hybond-C membranes at 4 °C (Amersham Pharmacia Biotech) using standard procedures. The membranes were blocked with 5%
milk powder in phosphate-buffered saline containing 0.05% Tween 20 (PBS-T) overnight. The membranes were incubated for 60 min at room
temperature with a monoclonal antibody raised against GR DNA-binding
domain (kindly provided by Ann-Charlotte Wikström and Marika
Rönnholm, Department of Medical Nutrition, Karolinska Institutet)
in PBS-T. After washing, the membranes were incubated with horseradish
peroxidase-linked sheep anti-mouse immunoglobulin G antibody (Amersham
Pharmacia Biotech) in PBS-T for 60 min. The membranes were then
thoroughly washed and developed using chemiluminescence with an ECL
mixture (68 mM p-coumaric acid, 1.25 mM luminol in Tris, pH 8.5, 0.009%
H2O2).
Total RNA Isolation and Northern Blotting
Transformant W303-1A cells were grown as described above under
"Transactivation Assay in Yeast." Total RNA was prepared as described by Schmitt et al. (35) and then run on denaturing MOPS gels and blotted onto Hybond-N filters (Amersham Pharmacia Biotech) as described in Ref. 36. For prehybridization, hybridization, washing, and detection, the Gene Images CDP-Star detection
module (Amersham Pharmacia Biotech) was used according to the
manufacturer's instructions. Preparation of fluorescein-labeled probes
for hybridization was done using the Gene Images random-prime labeling
module (Amersham Pharmacia Biotech) and with a GR-DBD PCR fragment and
a HindIII-BamHI actin fragment as templates.
Protein-Protein Interaction Assay
GST and GST fusion proteins were expressed and purified
essentially as described previously (30). PCR was run in which the different pKVBB-GRDBD plasmids served as templates and the following primers were used: 5'-CGAATTAACCCTCACTAAAGGGAACGCCGCCAC
CATGGTCAATTCGAGCTCAGGATCCCC-3' and 5'-TCAACCATGGTCAATTCCTTTTAT-3'.
[35S]Methionine-labeled proteins were generated by
in vitro transcription/translation of the PCR products
containing a 5'-T3 promotor using a TNT kit (Promega) at
30 °C for 90 min. The in vitro translated proteins were
incubated with approximately 1 µg of glutathione-Sepharose-bound GST
proteins in 200 µl of pull-down buffer (20 mM HEPES (pH
7.9), 10% (v/v) glycerol, 100 mM KCl, 0.2 mM
EDTA, 5 mM MgCl2, 0.2 mM phenylmethanesulfonyl fluoride, 1 mM dithiothreitol) also
containing Nonidet P-40 and bovine serum albumin to total
concentrations of 0.01% (v/v) and 1.5% (w/v), respectively.
Incubation with rotation was carried out at 4 °C for 2 h. Beads
were collected by centrifugation and washed three times with 400 µl
of pull-down buffer by rotating 15 min at 4 °C. Washed beads were
resuspended in 20 µl of 1 × SDS sample buffer, boiled for 10 min, and pelleted in a microcentrifuge. 10 µl of supernatant was
subjected to SDS-polyacrylamide gel electrophoresis (15%
polyacrylamide resolving gel). To monitor the stability and equal
loading of the GST fusion proteins, gels were stained with Coomassie
Blue before autoradiography.
H1 and H2 Segments Function as Interchangeable Modules That
Contribute Synergistically to Gene Activation--
A schematic
representation of the
To investigate whether the putative helical segments in the Low Expression of Constructs Containing Only H1 Modules Is Not Due
to Differences at the mRNA Level--
Because gene expression is
often regulated at the level of transcription, it is necessary to
investigate whether the observed differences in protein levels are due
to differences at the mRNA level. The transcript levels of selected
constructs were assayed by Northern blotting of total RNA extracted
from W303-1A yeast cells expressing the corresponding constructs using
probes that hybridize to GR DBD and actin (internal control) mRNA.
The results show that very similar amounts of mRNA were produced by
the different constructs (Fig. 4).
Consequently, the differences seen in protein expression levels for the
H1, H1-H1, and H1-H1-H1 constructs cannot be accounted for by
differences at the level of transcription but must originate at the
level of protein synthesis or protein stability.
Binding of Cofactors Ada2 and CBP to Mono-, Di-, and Trimodular
Constructs--
Ada2 and CBP proteins are coactivators known to bind
to the The Aromatic and hydrophobic amino acids are known to be important for
activity, as indicated by mutagenesis studies of acidic domains of GR
(14), VP16 (15-17), NF- Previous studies have shown an exquisite proportionality between
binding affinity and transcription potential for different It has been shown that different components of the transcription
initiation complex (e.g. TATA-binding protein, Ada2, and CBP) are able to bind to the The similar properties in terms of hydrophobicity, acidic amino acid
content, propensity for
1 activation
domain. This
1 core domain is unstructured in aqueous buffers, but
in the presence of trifluoroethanol three
-helical segments are
induced. Two of these putative structural modules have been tested in
different combinations with regard to transactivation potential
in vivo and binding capacity to the coactivators in
vitro. The results show that whereas single modules are not
transcriptionally active, any combination of two or three modules is
sufficient, with trimodular constructs having the highest activity.
However, proteins containing one, two, or three segments bind Ada2 and
cAMP-response element-binding protein with similar affinity. A single
segment is thus able to bind a target factor but cannot transactivate
target genes significantly. The results are consistent with models in
which activation domains are comprised of short activation modules that
allow multiple interactions with coactivators. Our results also suggest
that an increased number of modules may not result in correspondingly higher affinity but instead that the concentration of binding sites is
increased, which gives rise to a higher association rate. This is
consistent with a model where the association rate for activator-target
factor interactions rather than the equilibrium constant is the most
relevant measure of activator potency.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 (residues 77-262), which resides at the N terminus of
the protein, and
2 (residues 526-556), which is localized just
C-terminally of the DNA-binding domain (DBD) (8, 9). A small region at the C terminus of the receptor may also play a role in GR-mediated transcription (10). The
1 domain constitutes the major
transactivation function in the GR, and this domain represents the only
autonomous activation region within the GR N terminus (9). When fused to a DNA-binding domain,
1 constitutively activates transcription both in vivo and in vitro (11, 12). A 58-amino
acid segment that represents the core activation domain (the
1 core)
has been localized to residues 187-244 (13). This domain retains
60-70% of the activity conferred by the intact
1 domain (13). The
1 core domain belongs to the group of acidic activators because of
its relative abundance of acidic amino acid residues. Mutagenesis studies of the
1 core domain (14) and of acidic activation domains
in VP16 (15-17), GCN4 (5, 18), NF-
B p65 (2), p53 (19), and HNF-4
(20) have shown that hydrophobic amino acids are important for
transactivation activity of both isolated activation domains and intact
activator proteins.
B p65
(23), purified
1 and
1 core proteins have been shown to be
unstructured in aqueous solution as measured by circular dichroism and
NMR spectroscopy (24). However, in trifluoroethanol, the
1 core
forms
-helices, which is also consistent with studies of the VP16
(21) and NF-
B p65 (23) transactivation domains. Three putative
-helical regions in the
1 core have been identified by NMR
spectroscopy (25). Proline substitution mutants within two of the
putative helical regions reduce the transactivation activity of the
1 core and also its ability to form
-helices in trifluoroethanol
(24).
-Helix formation may thus be an important step in
1-mediated gene activation, and it is possible that target factor
interactions induce or stabilize a structured conformation in the
activation domain similar to the situation that has been demonstrated
for activation domains of p53 (26) and VP16 (27, 28).
1 core, the
-helices that can be
induced in the
1 core peptide can be considered as structural modules. In this study we wanted to further address whether the
1
core domain is composed of modules with distinct and independent functions or whether it should be viewed as a structurally integrated protein domain. The results reported here provide evidence for a model
in which the
1 core activation domain is built up of small modules
with acidic and hydrophobic character, each of which interacts with
target protein(s) to give efficient activation of transcription.
Furthermore, the ability of constructs consisting of duplicated and
triplicated modules of the same type to activate transcription suggests
that the individual segments do not carry determinants absolutely
critical for transactivation function.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 core and
pKVBB-GRDBD-
1-(187
227) express
1 core and
1-(187
227),
respectively, fused to the GR DBD. The plasmid pKVBB-GRDBD was
generated from plasmid pKV-XE (11) by destroying the existing
BamHI site and inserting a linker containing a
BamHI and a BglII site in the SacI
site. BamHI-BglII fragments corresponding to
1
core-H1 and
1 core-H2 were amplified by PCR using the following
primers: 5'-CAGCAGGGATCCCCTGACCAAAGCACCTTTGACAT-3' and
5'-CCACCAAGATCTATTCGTCTCTTTACCTGGGG-3' for the H1 fragment and
5'-CAGCAGGGATCCCCTTGGAGATCAGACCTGTTG-3' and
5'-CCACCAAGATCTATTCGTCTCTTTACCAGGAGAAAGCAAACAGTTTTC-3' for
the H2 fragment. In this way amino acid sequence GKETN (from the region
following the H1 segment) is joined to the end of the H2 module, thus
giving a similar linker sequence between any two segments in the
different combinations. Plasmid pKVBB-GRDBD expressing GR DBD was
cleaved with BamHI and BglII, and the PCR
fragments were inserted, resulting in plasmids pKVBB-GRDBD-H1 and
pKVBB-GRDBD-H2, respectively. To obtain pKVBB-GRDBD-H1-H1, -H1-H2,
-H2-H2, and -H2-H1, pKVBB-GRDBD-H1 and pKVBB-GRDBD-H2 were linearized
by BglII, and the BamHI-BglII PCR
fragments were inserted. The following trisegment plasmid constructs
were made using the same strategy: pKVBB-GRDBD-H1-H1-H1, -H1-H2-H1,
-H1-H1-H2, -H2-H1-H1, and -H2-H2-H2. The GR-responsive lacZ
reporter gene contains two glucocorticoid response elements from the
rat tyrosine aminotransferase promotor cloned upstream of a basal
CYC1-lacZ promotor and is contained in the vector
pLGZ-2xTAT, described previously (29). GST fusion plasmids pGEX-Ada2
and pGEX-CBP-C2 (amino acids 1678-1868) have been described previously
(30).
-galactopyranoside (X-gal) plates for homogeneity of transactivation activity (32). Representative transformants were grown in minimal medium with 2%
glucose for at least 18 h. The cultures were then diluted to an
A600 of 0.2 in minimal medium with 3% glycerol
and 1% ethanol and grown for 24 h. After 24 h the cultures
were diluted to an A600 of 0.2 in minimal medium
containing 2% galactose and cultured for an additional 4-5 h.
Extracts were prepared and assayed for
-galactosidase activity as
described previously (33).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 core transactivation domain of human GR is
shown in Fig. 1A. The location
of segments with propensity for
-helical formation as identified by
NMR is also shown. The amino acid sequences of the
1 core,
1-(187-227), H1, and H2 are shown in Fig. 1B.

View larger version (21K):
[in a new window]
Fig. 1.
Domain structure of GR and amino acid
sequences of the
1 fragments used.
A, schematic representation of the human glucocorticoid
receptor.
1 and
2 transactivation domains, the DBD, and the
steroid-binding domain (SBD) of the GR are indicated. The
1 core is indicated by a shaded box. The locations of
segments with propensity for
-helical conformation identified by NMR
are shown as cylinders. B, the amino acid
sequence of the
1 core,
1-(187-227), H1, and H2. The
BamHI site in the single H1 and H2 constructs gives rise to
amino acids Gly and Ser in the H1 and H2 proteins, whereas the
BglII/BamHI site that connects the different H1
and H2 modules in the other constructs gives rise to amino acids Arg
and Ser.
1 core
are interchangeable and to see how the transactivation activity is
affected by both the order and number of segments, different
combinations of H1 and H2 were fused to the GR DBD (Fig. 2). Previous mutagenesis and deletion
studies (13, 14) of the
1 core domain have indicated a less
important role for H3 compared with H1 and H2. Because of this and for
practical reasons in the experimental design, the H1 and H2 segments
were used in this study. The different proteins were expressed in yeast
cells in which expression of
-galactosidase is controlled by two
glucocorticoid-responsive elements. The
-galactosidase data obtained
from yeast strain W303-1A (Fig. 2) show that one segment only is not
enough for significant activation but that any combination of two
segments is sufficient to give transcriptional activation. The level of activation achieved with two segments is lower than for
1-(187-227) but still significant. Constructs containing three segments showed a
transactivation potential comparable with the wild type
1 core. The
exceptions are constructs containing only one type of module, i.e. the H1-H1-H1 and H2-H2-H2 proteins, which both had a
lower transactivation activity than did the wild type
1 core. By
these criteria, the H1 and H2 segments appear to function as
interchangeable modules that contribute synergistically to gene
activation. However, to be able to draw firm conclusions from the
transactivation activity data, the expression levels of the different
proteins were analyzed by Western blotting using an antibody against GR
DBD. Data in Fig. 3 show protein levels
to be very similar except for constructs containing only H1 segments,
which were expressed at a much lower level. With longer exposure times,
however, bands of the predicted size of H1, H1-H1, and H1-H1-H1 could
be detected (data not shown).

View larger version (32K):
[in a new window]
Fig. 2.
Transactivation potential of the
1 core,
1-(187-227), and
different H1 and H2 combinations in yeast cells. All activities
were normalized to that of the
1 core. The results represent mean
values (± S.D.) obtained from at least three independent experiments
for each construct tested.

View larger version (28K):
[in a new window]
Fig. 3.
Immunoblot analysis of expression levels of
the
1 core,
1-(187-227), and different H1 and H2
combinations. Aliquots containing equivalent amounts of protein
from whole cell yeast extracts were separated by SDS-polyacrylamide gel
electrophoresis and transferred to nitrocellulose filters. The GR DBD
fusion proteins were detected with an antibody against GR DBD.

View larger version (54K):
[in a new window]
Fig. 4.
Northern blot analysis of mRNA levels in
yeast strains expressing H1 and H2 fusion proteins. Total RNA was
extracted from W303-1A yeast cells expressing each of the tested
constructs. The mRNA transcripts were detected using probes that
hybridize to GR DBD or actin (internal control) mRNA.
1 core (30, 37). To test whether the binding capacity of the
1 core to coactivators correlates with the demonstrated
transcriptional activity, an in vitro protein-protein
interaction assay was performed using GST-Ada2 and GST-CBP-C2 fusion
proteins and the [35S]methionine-labeled in
vitro translated
1 core and different H segment proteins. As
shown in Fig. 5A, proteins
containing one, two, or three H2 segments resulted in similar binding
to both Ada2 and CBP-C2, but no binding to GST alone was seen.
Furthermore, several constructs containing combinations of H1 and H2
modules did not show significantly higher binding affinity (Fig.
5B). The
1 core included in the experiment as a control
showed a similar binding affinity to that of the other constructs.
Thus, the substantially higher activity seen in the transactivation
experiments for the multisegment constructs is not due to a
dramatically higher affinity for target factor binding.

View larger version (45K):
[in a new window]
Fig. 5.
Protein-protein interactions of the
1 core and different H1 and H2 combinations with
Ada2 and CBP-C2. Binding of the
[35S]methionine-labeled in vitro translated
1 core or different H1 and H2 combinations to GST, GST-Ada2, or
GST-CBP-C2. The input lanes represent 10% of the amount of labeled
protein used in each pull-down. A, the effect of the number
of H2 segments is shown. B, the effect of including H1 in
different combinations with H2 is shown.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 core activation domain of GR contains three putative
-helical structural segments (25) that have been shown previously to
have an important role in the transcriptional activation function of
the GR receptor (30). In this study we have used a hybrid protein
approach involving different combinations of the H1 and H2 activation
submodules of the
1 core to analyze the functional dependence on the
modular structure. The purpose of the study was to address whether the
1 core region should be viewed as a structurally integrated domain
or as composed of redundant submodules. We have demonstrated that
isolated H1 and H2 segments do not have significant residual activities
on their own (Fig. 2). We have further shown that duplication of H1 and
H2 segments in different combinations is sufficient for transcriptional
activation. Results obtained with the duplication constructs also
showed that neither segment carries unique determinants absolutely
critical for transactivation function. In addition, trimodular
constructs gave rise to higher transactivation activity than the
duplication constructs, reaching levels comparable with the wild type
1 core. These results support the model, mentioned in the
introduction, in which activation domains are composed of short, partly
redundant modules (1-5).
B p65 (2), and HNF-4 (20). Furthermore,
-helical structure formation of acidic activator domains upon
binding to putative target factors has been demonstrated in circular
dichroism studies of the c-Myc activation domain bound to TATA-binding
protein (38), crystal structure studies of the p53 activation domain
bound to MDM2 (26), fluorescence analyses of the interaction of the
VP16 activator domain with TATA-binding protein (27), and NMR studies
of the VP16 activator domain upon interaction with TAF31 (28). These
studies are consistent with an induced fit model for the folding of an
otherwise unstructured activator domain. These findings together with
the ability of the H1-only or H2-only proteins (e.g. H1-H1
and H2-H2) to activate transcription, shown here, suggest that
secondary structure formation and/or formation of hydrophobic surfaces
are likely to be more important for transcriptional activation than the
primary amino acid sequence as such. However, our study also indicates
that the two modules H1 and H2 are functionally distinct, at least in
part. First, combinations of H1 and H2 are always better activators than H1-only or H2-only alternatives. Second, the H2 module has a
positive effect on the protein levels of the constructs in which it is
contained. Presumably, it either facilitates production or perhaps more
likely stabilizes these proteins. In addition, H1 may have higher
activation potential than H2 because a comparably high transactivation
was observed for the relatively low protein levels of the H1-only constructs.
1 core
amino acid substitution mutants (30). It was therefore important to
show whether this is also true for the constructs described here, which
differ widely in activity. The results show that the different
constructs bind each target factor, Ada2 or CBP, with similar affinity
(Fig. 5). The dramatically higher transactivation observed for the
trimodular constructs (of different combinations) compared with the
mono-modular constructs is therefore not due to an increased overall
binding affinity to target factors. Thus, large deletions in the
1
core do not change target factor binding affinity but severely affect
transactivation potential so that the previously observed
proportionality between binding affinity and transactivation activity
is lost. An explanation probably lies in the fact that the number of
binding modules was kept constant in the previous study (with the
full-length
1 core) whereas it was varied in the present study.
1 core domain (30, 37, 39). That
several transcription factors and coactivators are molecular targets
for acidic activators has also been shown for activators such as VP16,
NF-
B p65, and HNF-4. Examples of targets include TATA-binding
protein, TFIIB, TAFII31, TAFII80, CBP, Ada2, and PC4 (20, 40-42).
Protein-protein in vitro interaction assays monitor binding
affinity for one target factor at a time, whereas transactivation
assays measure transcription activity in vivo where many
different target factors/coactivators are present. Our results could
therefore imply that multiple interactions are required for efficient
transactivation. The stoichiometry of the binding of the
1 core to
target proteins has not been determined. The presence of multiple
redundant modules would also increase the concentration of binding
sites that can interact with the target factors and thereby give rise
to a higher association rate. The requirement for multiple modules, as
demonstrated in this study, thus suggests that the modular architecture
of the activation domain may underlie its ability to activate gene
transcription by influencing the kinetics through changes in
association rate of its interaction with one or more target factors.
This model would be consistent with our previous results showing
proportionality between activation potential and binding affinity in
1 core mutants if the affinity changes observed for these mutants
are also accompanied by changes in target factor interaction kinetics.
In the future, direct association and dissociation measurements have to
be made to test this model.
-helical formation, and modular structure of
the
1 core and other acidic activation domains could reflect a
general mechanism for such activators, which would involve complex and
dynamic interactions with different target factors acting
synergistically to achieve efficient activation of transcription.
| |
ACKNOWLEDGEMENTS |
|---|
We thank members of the Steroid Receptor Unit at the Department of Biosciences for helpful comments during this work, Stefan Hermann and Tova Almlöf for fruitful discussions, and Ann-Charlotte Wikström and Marika Rönnholm for generously providing the monoclonal antibody against GR DBD.
| |
FOOTNOTES |
|---|
* This work was supported by Swedish Natural Sciences Research Council Grants KU9756 and LS9756 and Swedish Medical Research Council Grant 13x-2819.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 46 8 608 91 55; Fax: 46 8 774 55 38; E-mail: anette.warnmark@cbt.ki.se.
Published, JBC Papers in Press, March 20, 2000, DOI 10.1074/jbc.M001007200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: GR, glucocorticoid receptor; DBD, DNA-binding domain; GST, glutathione S-transferase; PCR, polymerase chain reaction; CBP, cAMP-response element-binding protein; MOPS, 4-morpholinepropanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Sutherland, J. A., Cook, A., Bannister, A. J., and Kouzarides, T. (1992) Genes Dev. 6, 1810-1819 |
| 2. | Blair, W. S., Bogerd, H. P., Madore, S. J., and Cullen, B. R. (1994) Mol. Cell. Biol. 14, 7226-7234 |
| 3. | Nerlov, C., and Ziff, E. B. (1994) Genes Dev. 8, 350-362 |
| 4. | Nerlov, C., and Ziff, E. B. (1995) EMBO J. 14, 4318-4328 |
| 5. | Jackson, B. M., Drysdale, C. M., Natarajan, K., and Hinnebusch, A. G. (1996) Mol. Cell. Biol. 16, 5557-5571 |
| 6. | Beato, M., Herrlich, P., and Schutz, G. (1995) Cell 83, 851-857 |
| 7. | Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R. M. (1995) Cell 83, 835-839 |
| 8. | Giguere, V., Hollenberg, S. M., Rosenfeld, M. G., and Evans, R. M. (1986) Cell 46, 645-652 |
| 9. | Hollenberg, S. M., and Evans, R. M. (1988) Cell 55, 899-906 |
| 10. | Danielian, P. S., White, R., Lees, J. A., and Parker, M. G. (1992) EMBO J. 11, 1025-1033 |
| 11. | Wright, A. P., McEwan, I. J., Dahlman-Wright, K., and Gustafsson, J. A. (1991) Mol. Endocrinol. 5, 1366-1372 |
| 12. | McEwan, I. J., Wright, A. P., Dahlman-Wright, K., Carlstedt-Duke, J., and Gustafsson, J. A. (1993) Mol. Cell. Biol. 13, 399-407 |
| 13. | Dahlman-Wright, K., Almlöf, T., McEwan, I. J., Gustafsson, J. A., and Wright, A. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 1619-1623 |
| 14. | Almlöf, T., Gustafsson, J. A., and Wright, A. P. (1997) Mol. Cell. Biol. 17, 934-945 |
| 15. | Cress, W. D., and Triezenberg, S. J. (1991) Science 251, 87-90 |
| 16. | Regier, J. L., Shen, F., and Triezenberg, S. J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 883-887 |
| 17. | Sullivan, S. M., Horn, P. J., Olson, V. A., Koop, A. H., Niu, W., Ebright, R. H., and Triezenberg, S. J. (1998) Nucleic Acids Res. 26, 4487-4496 |
| 18. | Drysdale, C. M., Duenas, E., Jackson, B. M., Reusser, U., Braus, G. H., and Hinnebusch, A. G. (1995) Mol. Cell. Biol. 15, 1220-1233 |
| 19. | Lin, J., Chen, J., Elenbaas, B., and Levine, A. J. (1994) Genes Dev. 8, 1235-1246 |
| 20. | Green, V. J., Kokkotou, E., and Ladias, J. A. (1998) J. Biol. Chem. 273, 29950-29957 |
| 21. | Donaldson, L., and Capone, J. P. (1992) J. Biol. Chem. 267, 1411-1414 |
| 22. | O'Hare, P., and Williams, G. (1992) Biochemistry 31, 4150-4156 |
| 23. | Schmitz, M. L., dos Santos Silva, M. A., Altmann, H., Czisch, M., Holak, T. A., and Baeuerle, P. A. (1994) J. Biol. Chem. 269, 25613-25620 |
| 24. | Dahlman-Wright, K., and McEwan, I. J. (1996) Biochemistry 35, 1323-1327 |
| 25. | Dahlman-Wright, K., Baumann, H., McEwan, I. J., Almlöf, T., Wright, A. P., Gustafsson, J. A., and Hard, T. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1699-1703 |
| 26. | Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., and Pavletich, N. P. (1996) Science 274, 948-953 |
| 27. | Shen, F., Triezenberg, S. J., Hensley, P., Porter, D., and Knutson, J. R. (1996) J. Biol. Chem. 271, 4827-4837 |
| 28. | Uesugi, M., Nyanguile, O., Lu, H., Levine, A. J., and Verdine, G. L. (1997) Science 277, 1310-1313 |
| 29. | Wright, A. P., and Gustafsson, J. A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 8283-8287 |
| 30. | Almlöf, T., Wallberg, A. E., Gustafsson, J. A., and Wright, A. P. (1998) Biochemistry 37, 9586-9594 |
| 31. | Beggs, J. D. (1978) Nature 275, 104-109 |
| 32. | Bohen, S. P., and Yamamoto, K. R. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11424-11428 |
| 33. | Wright, A. P., Carlstedt-Duke, J., and Gustafsson, J. A. (1990) J. Biol. Chem. 265, 14763-14769 |
| 34. | Horvath, A., and Riezman, H. (1994) Yeast 10, 1305-1310 |
| 35. | Schmitt, M. E., Brown, T. A., and Trumpower, B. L. (1990) Nucleic Acids Res. 18, 3091-3092 |
| 36. | Brown, T. (1994) in Current Protocols in Molecular Biology (Ausubel, F. M. , Brent, R. , Kingston, R. E. , Moore, D. D. , Seidman, J. G. , Smith, J. A. , and Struhl, K., eds), Vol. 1 , pp. 4.9.1-4.9.14, John Wiley & Sons, Inc., New York |
| 37. | Henriksson, A., Almlöf, T., Ford, J., McEwan, I. J., Gustafsson, J. A., and Wright, A. P. (1997) Mol. Cell. Biol. 17, 3065-3073 |
| 38. | McEwan, I. J., Dahlman-Wright, K., Ford, J., and Wright, A. P. (1996) Biochemistry 35, 9584-9593 |
| 39. | Ford, J., McEwan, I. J., Wright, A. P., and Gustafsson, J. A. (1997) Mol. Endocrinol. 11, 1467-1475 |
| 40. | Stringer, K. F., Ingles, C. J., and Greenblatt, J. (1990) Nature 345, 783-786 |
| 41. | Lin, Y. S., Ha, I., Maldonado, E., Reinberg, D., and Green, M. R. (1991) Nature 353, 569-571 |
| 42. | Triezenberg, S. J. (1995) Curr. Opin. Genet. Dev. 5, 190-196 |
This article has been cited by other articles:
![]() |
E. Estebanez-Perpina, L. A. Arnold, N. Jouravel, M. Togashi, J. Blethrow, E. Mar, P. Nguyen, K. J. Phillips, J. D. Baxter, P. Webb, et al. Structural Insight into the Mode of Action of a Direct Inhibitor of Coregulator Binding to the Thyroid Hormone Receptor Mol. Endocrinol., December 1, 2007; 21(12): 2919 - 2928. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Callewaert, N. Van Tilborgh, and F. Claessens Interplay between Two Hormone-Independent Activation Domains in the Androgen Receptor Cancer Res., January 1, 2006; 66(1): 543 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Friedman, H. Khanna, P. K. Swain, R. DeNicola, H. Cheng, K. P. Mitton, C. H. Weber, D. Hicks, and A. Swaroop The Minimal Transactivation Domain of the Basic Motif-Leucine Zipper Transcription Factor NRL Interacts with TATA-binding Protein J. Biol. Chem., November 5, 2004; 279(45): 47233 - 47241. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. U. DE MARTINO, S. ALESCI, G. P. CHROUSOS, and T. KINO Interaction of the Glucocorticoid Receptor and the Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII): Implications for the Actions of Glucocorticoids on Glucose, Lipoprotein, and Xenobiotic Metabolism Ann. N.Y. Acad. Sci., June 1, 2004; 1024(1): 72 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Warnmark, E. Treuter, A. P. H. Wright, and J.-A. Gustafsson Activation Functions 1 and 2 of Nuclear Receptors: Molecular Strategies for Transcriptional Activation Mol. Endocrinol., October 1, 2003; 17(10): 1901 - 1909. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar and E. B. Thompson Transactivation Functions of the N-Terminal Domains of Nuclear Hormone Receptors: Protein Folding and Coactivator Interactions Mol. Endocrinol., January 1, 2003; 17(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hermann, K. D. Berndt, and A. P. Wright How Transcriptional Activators Bind Target Proteins J. Biol. Chem., October 19, 2001; 276(43): 40127 - 40132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Zennaro, A. Souque, S. Viengchareun, E. Poisson, and M. Lombes A New Human MR Splice Variant Is a Ligand-Independent Transactivator Modulating Corticosteroid Action Mol. Endocrinol., September 1, 2001; 15(9): 1586 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar, J. C. Lee, D. W. Bolen, and E. B. Thompson The Conformation of the Glucocorticoid Receptor AF1/tau1 Domain Induced by Osmolyte Binds Co-regulatory Proteins J. Biol. Chem., May 18, 2001; 276(21): 18146 - 18152. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |